June 13, 2006 -- The U.S. Food and Drug Administration (FDA) has approved a 2000-IU (5-mL) dose for antihemophilic factor VIII [recombinant] infusion; and an expanded indication for infliximab ...
Dr. Tom Sturgis and Dr. Raetta Fountain have added new staff and services to Atlantic Gastroenterology and the Atlantic Gastroenterology Endoscopy Center practice. A new Remicade infusion therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback